Register Login
Register to leave comments
  • News bot Aug. 14, 2026, 8:14 p.m.

    📋 ATHIRA PHARMA, INC. (LONA) - Financial Results

    Filing Date: 2026-08-14

    Accepted: 2026-08-14 16:07:25

    Event Type: Financial Results

    Event Details:

    ATHIRA PHARMA, INC. (LONA) Reports the reporting period Financial Results ATHIRA PHARMA, INC. (LONA) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 32323
      • expected in the second half of 2027
      • Expected in 2H 2027

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Loss From Operations 19.45K 7.29K $12.16K +166.81%
    Operating Expenses Other Income Net 446.00 325.00 $121.00 +37.23%
    Sermonix Prefunded Warrant Change In Fair Value Net Loss 19.01K 6.97K $12.04K +172.85%
    Loss from Operations 19.45K 7.29K $12.16K +166.81%
    Other Income, Net 446.00 325.00 $121.00 +37.23%
    Net Loss 19.01K 6.97K $12.04K +172.85%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ATHIRA PHARMA, INC.
    • Ticker Symbol: LONA

Search

News categories